Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

IBB vs. FBT: which is better?

Bottom line

IBB vs FBT: the short answer

IBB (iShares Biotechnology ETF) and FBT (First Trust NYSE Arca Biotechnology Index Fund) are quite different portfolios: only about 30% of their top holdings (by weight) are shared.

But IBB is far broader, holding 254 positions to 32 for FBT, so beyond the top names it adds exposure FBT doesn't have.

IBB is cheaper at 0.44% vs 0.55% — a difference of $11 a year per $10,000 invested.

Over five years, FBT returned +4.3% a year vs +2.5% for IBB.

Updated Nov 19, 2026

IBB vs FBT side by side

IBBFBT
TypeETFETF
Fund familyiSharesFirst Trust
CategoryTechnology SectorTechnology Sector
Expense ratio0.44%0.55%
Annual cost per $10k$44$55
10-yr cost on $10k (prospectus)$555—
Max front loadNoneNone
12b-1 fee0%0%
1-yr return+28.0%+24.1%
5-yr return (annualized)+2.5%+4.3%
10-yr return (annualized)+4.4%+6.3%
Best quarter+26.8%+27.8%
Worst quarter−22.9%−22.5%
Net assets (fund)$5.9B$2.8B
Number of holdings25432
Portfolio turnover27%37%
Returns as ofDec 31, 2025Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearIBBFBTDifference
2025+28.0%+24.1%+3.9%
2024−2.4%+5.8%−8.2%
2023+3.6%+2.3%+1.4%
2022−13.6%−4.6%−9.0%
2021+1.0%−3.6%+4.6%
2020+25.9%+12.9%+13.0%
2019+24.8%+19.8%+5.0%
2018−9.1%−0.2%−8.9%
2017+21.2%+37.0%−15.8%
2016−21.5%−19.6%−1.9%

Source: Fund prospectus bar charts

Holdings overlap

13 of IBB's top 25 holdings also appear in FBT's top 25.

Shared top holdings
HoldingIBBFBT
Vertex Pharmaceuticals, Inc.7.66%3.07%
Amgen, Inc.7.50%2.78%
Alnylam Pharmaceuticals, Inc.5.68%2.52%
Argenx SE3.15%3.13%
Natera, Inc.2.11%3.79%
Biogen, Inc.2.03%3.37%
United Therapeutics Corp.1.82%2.56%
Incyte Corp.1.62%3.18%
Illumina, Inc.1.41%3.92%
Genmab A/S1.38%2.62%
Neurocrine Biosciences, Inc.1.34%3.53%
Exelixis, Inc.1.07%3.32%
BioMarin Pharmaceutical, Inc.1.02%2.83%

Source: SEC Form N-PORT

IBB top 10

  1. BlackRock Funds III — 13.18%
  2. Vertex Pharmaceuticals, Inc. — 7.66%
  3. Gilead Sciences, Inc. — 7.52%
  4. Amgen, Inc. — 7.50%
  5. Regeneron Pharmaceuticals, Inc. — 5.70%
  6. Alnylam Pharmaceuticals, Inc. — 5.68%
  7. IQVIA Holdings, Inc. — 3.18%
  8. Argenx SE — 3.15%
  9. Insmed, Inc. — 2.95%
  10. Mettler-Toledo International, Inc. — 2.49%

FBT top 10

  1. Corcept Therapeutics Inc — 5.60%
  2. Neogenomics Inc — 5.12%
  3. Veracyte Inc — 5.10%
  4. Bruker Corp — 4.32%
  5. Alkermes Plc — 4.24%
  6. Illumina Inc — 3.92%
  7. Krystal Biotech Inc — 3.87%
  8. Natera Inc — 3.79%
  9. Axsome Therapeutics Inc — 3.71%
  10. Neurocrine Biosciences Inc — 3.53%

FAQ

What is the difference between IBB and FBT?
IBB (iShares Biotechnology ETF) and FBT (First Trust NYSE Arca Biotechnology Index Fund) are quite different portfolios: only about 30% of their top holdings (by weight) are shared. But IBB is far broader, holding 254 positions to 32 for FBT, so beyond the top names it adds exposure FBT doesn't have.
Which is cheaper, IBB or FBT?
IBB has the lower expense ratio (0.44%).
Should I own both IBB and FBT?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.